drugset / Trial / NCT01341158
NAM-Trial: Multiferon in Malignant Melanoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The current clinical trial shall clarify the efficacy, safety and biologic effects of neoadjuvant treatment with natural interferon-α (Multiferon) in patients with locoregional metastases of melanoma in stage IIIB/C.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human interferon-α | Protein / enzyme biologic | 3e+06 iu | Subcutaneous |
| Subject | human interferon-α | Protein / enzyme biologic | 9e+06 iu | Subcutaneous |
| Subject | human interferon-α | Protein / enzyme biologic | 1.8e+07 iu | Subcutaneous |